GALVUS Trademark

Trademark Overview


On Friday, November 1, 2019, a trademark application was filed for GALVUS with the United States Patent and Trademark Office. The USPTO has given the GALVUS trademark a serial number of 88676989. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 29, 2023. This trademark is owned by Novartis AG. The GALVUS trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preve...
galvus

General Information


Serial Number88676989
Word MarkGALVUS
Filing DateFriday, November 1, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 29, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2020

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma
Translation of Words in MarkThe wording "GALVUS" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 5, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4002
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel 4002
CH

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 29, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 17, 2022SOU EXTENSION 5 GRANTED
Thursday, October 6, 2022SOU EXTENSION 5 FILED
Monday, October 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 6, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, April 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2022SOU EXTENSION 4 GRANTED
Monday, April 25, 2022SOU EXTENSION 4 FILED
Monday, April 25, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, October 23, 2021SOU EXTENSION 3 GRANTED
Saturday, October 23, 2021SOU EXTENSION 3 FILED
Saturday, October 23, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 23, 2021SOU EXTENSION 2 GRANTED
Friday, April 23, 2021SOU EXTENSION 2 FILED
Friday, April 23, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, October 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 26, 2020SOU EXTENSION 1 GRANTED
Monday, October 26, 2020SOU EXTENSION 1 FILED
Monday, October 26, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 30, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 30, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 30, 2020ASSIGNED TO LIE
Monday, January 27, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 15, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 15, 2020NON-FINAL ACTION E-MAILED
Wednesday, January 15, 2020NON-FINAL ACTION WRITTEN
Friday, January 3, 2020ASSIGNED TO EXAMINER
Tuesday, November 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 5, 2019NEW APPLICATION ENTERED